These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26691574)

  • 1. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics.
    Malik UU; Zarina S; Pennington SR
    Arch Oral Biol; 2016 Mar; 63():53-65. PubMed ID: 26691574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Cancer: Genetics and the Role of Precision Medicine.
    Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
    Dent Clin North Am; 2018 Jan; 62(1):29-46. PubMed ID: 29126492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
    Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
    Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature.
    Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG
    J BUON; 2011; 16(4):613-6. PubMed ID: 22331711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essentials of oral cancer.
    Rivera C
    Int J Clin Exp Pathol; 2015; 8(9):11884-94. PubMed ID: 26617944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis.
    Wang Z; Feng X; Liu X; Jiang L; Zeng X; Ji N; Li J; Li L; Chen Q
    BMC Genomics; 2009 Aug; 10():383. PubMed ID: 19691830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-375 as a biomarker for malignant transformation in oral lesions.
    Harrandah AM; Fitzpatrick SG; Smith MH; Wang D; Cohen DM; Chan EK
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):743-752.e1. PubMed ID: 27720656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.
    Nikitakis NG; Pentenero M; Georgaki M; Poh CF; Peterson DE; Edwards P; Lingen M; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):650-669. PubMed ID: 29709496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis.
    Yang Y; Li YX; Yang X; Jiang L; Zhou ZJ; Zhu YQ
    BMC Cancer; 2013 Mar; 13():129. PubMed ID: 23510112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
    Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
    Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
    Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Dattagupta S; Thakar A; Chauhan SS; Siu KW
    J Proteome Res; 2009 Jan; 8(1):300-9. PubMed ID: 19072117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promising impact of molecular profiling on treatment strategies in oral cancers.
    Foy JP; Saintigny P; Goudot P; Schouman T; Bertolus C
    J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):242-247. PubMed ID: 28576460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based investigation of multiple stages of OSCC development indicates that the inhibition of Trx-1 delays oral malignant transformation.
    Chen X; Hu Q; Wu T; Wang C; Xia J; Yang L; Cheng B; Chen X
    Int J Oncol; 2018 Mar; 52(3):733-742. PubMed ID: 29328386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics.
    Irimie AI; Braicu C; Cojocneanu-Petric R; Berindan-Neagoe I; Campian RS
    Acta Odontol Scand; 2015 Apr; 73(3):161-8. PubMed ID: 25598447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
    Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
    PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation.
    Ni YH; Ding L; Hu QG; Hua ZC
    Proteomics Clin Appl; 2015 Feb; 9(1-2):86-97. PubMed ID: 25431113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
    Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
    J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.